BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27181190)

  • 1. Ataxia-telangiectasia (A-T): An emerging dimension of premature ageing.
    Shiloh Y; Lederman HM
    Ageing Res Rev; 2017 Jan; 33():76-88. PubMed ID: 27181190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hallmarks of aging in Ataxia-Telangiectasia.
    Aguado J; Gómez-Inclán C; Leeson HC; Lavin MF; Shiloh Y; Wolvetang EJ
    Ageing Res Rev; 2022 Aug; 79():101653. PubMed ID: 35644374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ataxia-telangiectasia: mild neurological presentation despite null ATM mutation and severe cellular phenotype.
    Alterman N; Fattal-Valevski A; Moyal L; Crawford TO; Lederman HM; Ziv Y; Shiloh Y
    Am J Med Genet A; 2007 Aug; 143A(16):1827-34. PubMed ID: 17632790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Syndrome of premature ageing in ataxia-telangiectasia patients].
    Polubot'ko EA; Smirnova NV; Pleskach NM; Mikhel'son VM; Spivak IM
    Tsitologiia; 2009; 51(8):712-8. PubMed ID: 19799357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ataxia-telangiectasia: A review of clinical features and molecular pathology.
    Amirifar P; Ranjouri MR; Yazdani R; Abolhassani H; Aghamohammadi A
    Pediatr Allergy Immunol; 2019 May; 30(3):277-288. PubMed ID: 30685876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage.
    Barzilai A; Rotman G; Shiloh Y
    DNA Repair (Amst); 2002 Jan; 1(1):3-25. PubMed ID: 12509294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired genomic stability and increased oxidative stress exacerbate different features of Ataxia-telangiectasia.
    Ziv S; Brenner O; Amariglio N; Smorodinsky NI; Galron R; Carrion DV; Zhang W; Sharma GG; Pandita RK; Agarwal M; Elkon R; Katzin N; Bar-Am I; Pandita TK; Kucherlapati R; Rechavi G; Shiloh Y; Barzilai A
    Hum Mol Genet; 2005 Oct; 14(19):2929-43. PubMed ID: 16150740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress in ataxia telangiectasia.
    Watters DJ
    Redox Rep; 2003; 8(1):23-9. PubMed ID: 12631440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATM signaling and genomic stability in response to DNA damage.
    Lavin MF; Birrell G; Chen P; Kozlov S; Scott S; Gueven N
    Mutat Res; 2005 Jan; 569(1-2):123-32. PubMed ID: 15603757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of the ATM gene in two Chinese patients with ataxia telangiectasia.
    Jiang H; Tang B; Xia K; Hu Z; Shen L; Tang J; Zhao G; Zhang Y; Cai F; Pan Q; Long Z; Wang G; Dai H
    J Neurol Sci; 2006 Feb; 241(1-2):1-6. PubMed ID: 16380133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATM: genome stability, neuronal development, and cancer cross paths.
    Shiloh Y; Kastan MB
    Adv Cancer Res; 2001; 83():209-54. PubMed ID: 11665719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurological phenotype of ataxia-telangiectasia: solving a persistent puzzle.
    Biton S; Barzilai A; Shiloh Y
    DNA Repair (Amst); 2008 Jul; 7(7):1028-38. PubMed ID: 18456574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ataxia telangiectasia syndrome: moonlighting ATM.
    Zaki-Dizaji M; Akrami SM; Abolhassani H; Rezaei N; Aghamohammadi A
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1155-1172. PubMed ID: 29034753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATM and ataxia telangiectasia.
    McKinnon PJ
    EMBO Rep; 2004 Aug; 5(8):772-6. PubMed ID: 15289825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of ATM mutations in Slavic Ataxia telangiectasia patients.
    Soukupova J; Pohlreich P; Seemanova E
    Neuromolecular Med; 2011 Sep; 13(3):204-11. PubMed ID: 21833744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cerebellar degeneration in ataxia-telangiectasia: A case for genome instability.
    Shiloh Y
    DNA Repair (Amst); 2020 Nov; 95():102950. PubMed ID: 32871349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATM and the molecular pathogenesis of ataxia telangiectasia.
    McKinnon PJ
    Annu Rev Pathol; 2012; 7():303-21. PubMed ID: 22035194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The appropriateness of the mouse model for ataxia-telangiectasia: neurological defects but no neurodegeneration.
    Lavin MF
    DNA Repair (Amst); 2013 Aug; 12(8):612-9. PubMed ID: 23731731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetic defect in ataxia-telangiectasia.
    Lavin MF; Shiloh Y
    Annu Rev Immunol; 1997; 15():177-202. PubMed ID: 9143686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATM-dependent phosphorylation of nibrin in response to radiation exposure.
    Gatei M; Young D; Cerosaletti KM; Desai-Mehta A; Spring K; Kozlov S; Lavin MF; Gatti RA; Concannon P; Khanna K
    Nat Genet; 2000 May; 25(1):115-9. PubMed ID: 10802669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.